Active Pharmaceutical Ingredient

We are dedicated in developing top of the line pharmaceutical products while adhering to highest quality norms by well qualified and renowned research team. The continuous strive for perfection has led us to push our standards of manufacturing by building state-of-the-art facilities.

Today these state-of-the-art manufacturing facilities and infrastructure facilitate Delvin ‘s Growth in the regulated markets.

“Our vision to create a Vertically Integrated Organization offering broad spectrum of products with a competitive edge in Global markets has led us to set up of very own API Manufacturing facility.

The well-planned and state-of-the-art facilities have led to its accelerated growth in the pharmaceutical sector. Infrastructure plays a key role in the development and progress of a company. The reputation of our company is built on Manufacturing and R&D facilities that are designed to meet global standards, and stringent Quality standards that ensure we deliver only the best formulations and products. The manufacturing units are designed to meet the current global standards of GMP and safety standards for personnel.
Sai Mirra Innopharm

Sai Mirra Innopharm is a PIC/s approved finished formulation manufacturer. 

  • The facility is situated in Chennai, Tamilnadu, India.
  • Sai Mirra Innopharm is exporting various finished formulations to over 40 countries.
  • The facility is approved by various African and ASEAN regulatory authorities for finished formulation.
  • The formulation research unit of Sai Mirra is approved by Department of Scientific and Industrial Research unit of Government of India.
  • The facility has got capacity to manufacture Tablets, Liquids, Capsules, Sachet granules, Sachet liquid and Soft gel.

NuRay Chemicals

R&D and Manufacturing of API (Bulk Drug) – Facility with USFDA approval

  • NuRay Chemicals is a US FDA approved API manufacturing facility situated in Chennai.
  • NuRay is having advanced R&D infrastructure and state of the art manufacturing facility.
  • NuRay is capable of developing commercially viable, eco-friendly, non-infringing and robust process of APIs and identification of novel polymorphic forms.
  • The facility has multiproduct classified area as per US Federal Standard 209E M6.5, capable of executing simultaneous and continuation production.